Fundraising Fox
Catalent
Somerset, US · Delaware corporation · 12,504 employees on LinkedIn · 4 known investors
Find your way into Catalent
Sign up to find every way you can get introduced to Catalent
- Your email: who you already know at Catalent, and who your contacts know
- 2nd- and 3rd-degree connections: people you know who worked, studied or invested with the Catalent team
- Your LinkedIn: the connections who can make the intro for you
We rank every route by how warm it is, so you raise on warm intros instead of cold emails.
Catalent is a global Contract Development and Manufacturing Organization (CDMO) that helps pharma, biotech, and self-care companies develop, manufacture, and deliver drug products and consumer health solutions. Its services span oral dose, biologics, specialty, and clinical supply, from early-stage design through commercial manufacturing.
Founders & leadership
Board
Investors · 4
How we know: Aisling Capital's portfolio page · Not right? Tell us
How we know: Leonard Green's portfolio page · Not right? Tell us
How we know: funding news · Not right? Tell us
Reported raises · per SEC filings
Form D private placements$650M disclosed across 1 of 2 rounds · 2019–2026
▶$650MraisedMay 2019 · 4 investors · PharmaceuticalsRule 506(b)
- John R. ChiminskiExecutive Officer, Director
- Jack L. StahlDirector
- Madhavan BalachandranDirector
- J. Martin CarrollDirector
- Rolf A. ClassonDirector
- Rosemary CraneDirector
- John J. GreischDirector
- Christa KreuzburgDirector
- Gregory T. LucierDirector
- Donald E. Morel Jr.Director
- Peter ZippeliusDirector
- Wetteny JosephExecutive Officer
- Alessandro MaselliExecutive Officer
- Steven L. FasmanExecutive Officer
- Offering amount
- $650M
- Amount sold
- $650M
- First sale
- May 2019
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Founder mafia
The Catalent mafia →6 people who came through Catalent went on to found or lead other companies.
In the news
Frequently asked questions
- What does Catalent do?
- Catalent is a global Contract Development and Manufacturing Organization (CDMO) that helps pharma, biotech, and self-care companies develop, manufacture, and deliver drug products and consumer health solutions. Its services span oral dose, biologics, specialty, and clinical supply, from early-stage design through commercial manufacturing.
- Who are Catalent's investors?
- Catalent's investors include Aisling Capital, Havencrest Capital Management, Leonard Green, Blackstone.
- How much funding has Catalent raised?
- Catalent has disclosed $650M raised across 1 of its 2 known rounds.
- Where is Catalent headquartered?
- Catalent is headquartered in Somerset, US.